Feeds
6810 items (6810 unread) in 74 feeds
Acinar Cell Carcinoma
(81 unread)
Acinic Cell Carcinoma
(46 unread)
Adenoid Cystic Carcinoma
(159 unread)
Adrenal Gland Cancer
(533 unread)
Ampulla Of Vater
(68 unread)
Anal Cancer
(425 unread)
Angiosarcoma
(153 unread)
Appendix Cancer
(104 unread)
Bile Duct Cancer
(845 unread)
Brain and CNS
(878 unread)
Carcinoid
(266 unread)
Endocrine/Neuroendocrine
(808 unread)
Gall Bladder Cancer
(381 unread)
Hemangioendothelioma
(215 unread)
Hepatoblastoma
(129 unread)
Pancreas
(117 unread)
Phyllodes
(105 unread)
PMP and Mucinous Tumors
(114 unread)
Rhabdomyosarcoma
(246 unread)
Sarcoma
(1137 unread)
Google - Neuroendocrine Tumor (100 unread)
-
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA in - GuruFocus.com
Posted: September 15th, 2021, 9:02pm GMT
-
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in - GlobeNewswire
Posted: September 15th, 2021, 8:06pm GMT
-
Roundtable Discussion: Borghaei Discusses Combination Therapies in NSCLC With High TMB - Targeted Oncology
Posted: September 15th, 2021, 8:00pm GMT
-
Hear a Pulse in Your Ear? Here's What Your Body's Trying to Tell You - Livestrong
Posted: September 15th, 2021, 7:09pm GMT
-
Europe Neuroendocrine Tumors Market Technological Advancements, Evolving Industry Trends And Insights 2021 – 2028 - Digital Journal
Posted: September 15th, 2021, 3:43pm GMT
-
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification - Cancer Network
Posted: September 14th, 2021, 4:02pm GMT
-
Two Distinct Classes of Thymic Tumors in Patients with MEN1 Show LOH at the MEN1 Locus - DocWire News
Posted: September 14th, 2021, 1:02pm GMT
-
Somatostatin Analogue Drug Market Report 2021: By Key Players, - openPR
Posted: September 14th, 2021, 5:43am GMT
-
Europe Neuroendocrine Tumors Market 2021 COVID-19 Impact - openPR
Posted: September 14th, 2021, 5:10am GMT
-
Harbour BioMed Announces NMPA Approval of Two IND Applications for Next-Generation Anti-CTLA-4 Antibody HBM4003 - PRNewswire
Posted: September 14th, 2021, 3:10am GMT
-
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer - pnas.org
Posted: September 13th, 2021, 5:40pm GMT
-
Clinical Catch-Up: September 6-10 - BioSpace
Posted: September 13th, 2021, 3:07pm GMT
Clinical Catch-Up: September 6-10 BioSpace -
Europe Neuroendocrine Tumors Market 2021 Size, Share, Trend & Analytical Overview, Technological Inn - PharmiWeb.com
Posted: September 13th, 2021, 2:18pm GMT
-
Two Distinct Classes of Thymic Tumors in Patients with MEN1 Show LOH at the MEN1 Locus - DocWire News
Posted: September 13th, 2021, 1:02pm GMT
-
FDA Action Alert: Calliditas, Merck and BeiGene - BioSpace
Posted: September 13th, 2021, 11:11am GMT
-
Tumor Microenvironment Predicts Efficacy of PD-1/PD-L1 Blockade in Non-Small Cell Lung Cancer - Cancer Therapy Advisor
Posted: September 13th, 2021, 11:00am GMT
-
Lantheus Announces Addition of PSMA PET Imaging Agent to the National Comprehensive Cancer ... - Post Register
Posted: September 13th, 2021, 10:00am GMT
-
Lantheus and RefleXion Announce Development and Commercialization Collaboration with the ... - KULR-TV
Posted: September 13th, 2021, 9:30am GMT
-
AUA 2021: AUA Guideline Amendment: Non-Muscle Invasive Bladder Cancer/Muscle Invasive Bladder Cancer - UroToday
Posted: September 13th, 2021, 5:00am GMT
-
BioXcel Therapeutics to Present Updates from Ongoing Trial - GlobeNewswire
Posted: September 12th, 2021, 8:05pm GMT
-
AUA 2021: AUA Guideline Amendment: Non-Muscle Invasive Bladder Cancer/Muscle Invasive Bladder Cancer - UroToday
Posted: September 12th, 2021, 4:11am GMT
-
AUA 2021: State-of-the-art Lecture: Personalized Medicine in the Management of Prostate Cancer Across the Patient Care Continuum - UroToday
Posted: September 12th, 2021, 11:00pm GMT
-
Nebraska Cancer Specialists offers physicians in central Nebraska - Fremont Tribune
Posted: September 11th, 2021, 11:45am GMT
-
What To Know About New Blood Tests to Find Pancreatic Cancer Early - Pancreatic Cancer News & Stories
Posted: September 10th, 2021, 7:47pm GMT
What To Know About New Blood Tests to Find Pancreatic Cancer Early Pancreatic Cancer News & Stories -
Pancreatic Endocrine Tumor Market Insights and Treatment Mar... - MENAFN.COM
Posted: September 10th, 2021, 3:24pm GMT
-
2-surgeon Bilateral Adrenalectomy May Be Better for Ectopic Cushing's - Cushing's Disease News
Posted: September 10th, 2021, 1:07pm GMT
2-surgeon Bilateral Adrenalectomy May Be Better for Ectopic Cushing's Cushing's Disease News -
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting - StreetInsider.com
Posted: September 10th, 2021, 10:34am GMT
-
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting - KULR-TV
Posted: September 10th, 2021, 10:30am GMT
-
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting - The Bakersfield Californian
Posted: September 10th, 2021, 10:30am GMT
Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting The Bakersfield Californian -
Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib - OncLive
Posted: September 10th, 2021, 10:01am GMT
-
Neuroendocrine small cell lung cancer: Stage 4 and more - Medical News Today
Posted: September 10th, 2021, 8:12am GMT
Neuroendocrine small cell lung cancer: Stage 4 and more Medical News Today -
CircPTCH1 promotes migration in lung cancer | OTT - Dove Medical Press
Posted: September 10th, 2021, 7:14am GMT
CircPTCH1 promotes migration in lung cancer | OTT Dove Medical Press -
Global Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market 2021 Report Segmented by Geography, Key Players, Product Type, Application and Forecast by 2027 - Big News Network
Posted: September 9th, 2021, 8:49pm GMT
-
'The Art of Deliberate Listening'; Access Tied to Outcomes; No 'A' in Cancer - MedPage Today
Posted: September 9th, 2021, 6:01pm GMT
-
Clive’s Moving Castle - Rolling Stone
Posted: September 9th, 2021, 3:03pm GMT
Clive’s Moving Castle Rolling Stone -
Viewpoint Molecular Targeting(TM) Receives FDA Clearance of Investigational New Drug Application for Phase 1 Imaging Study for VMT-a-NET for Neuroendocrine Tumors - Digital Journal
Posted: September 9th, 2021, 12:46pm GMT
-
Viewpoint Molecular Targeting(TM) Receives FDA Clearance of Investigational New Drug Application for Phase 1 Imaging Study for VMT-a-NET for Neuroendocrine Tumors - Yahoo Finance
Posted: September 9th, 2021, 12:00pm GMT
-
ITM to Host Virtual Symposium at the ESMO Congress 2021 with Key Neuroendocrine Tumor Experts on September 17, 2021 - Business Wire
Posted: September 9th, 2021, 7:00am GMT
-
Amgen Inc. (AMGN) Management Presents at Citi's 16th Annual BioPharma Virtual Conference (Transcript) - Seeking Alpha
Posted: September 8th, 2021, 9:09pm GMT
-
Paul Viscuse, MD, on Androgen-Indifferent Prostate Cancers - MedPage Today
Posted: September 8th, 2021, 12:01pm GMT
-
Paul Viscuse, MD, on Androgen-Indifferent Prostate Cancers - MedPage Today
Posted: September 8th, 2021, 12:01pm GMT
-
Anticancer Potential of Maslinic Acid and its Derivatives | DDDT - Dove Medical Press
Posted: September 8th, 2021, 11:52am GMT
Anticancer Potential of Maslinic Acid and its Derivatives | DDDT Dove Medical Press -
Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, Including in Earlier Stages of Cancer - Business Wire
Posted: September 8th, 2021, 8:45am GMT
-
Cancer-Specific Mortality Shows Variable Risk Throughout Neuroendocrine Tumors - OncLive
Posted: September 7th, 2021, 12:10pm GMT
-
Neutrophil-to-lymphocyte ratio in perioperative periods | JIR - Dove Medical Press
Posted: September 6th, 2021, 4:06pm GMT
Neutrophil-to-lymphocyte ratio in perioperative periods | JIR Dove Medical Press -
'Goals of Treatment for NETs Very Different From Other Cancers' - Medscape
Posted: September 6th, 2021, 2:51pm GMT
-
'Goals of Treatment for NETs Very Different From Other Cancers' - Medscape
Posted: September 6th, 2021, 2:51pm GMT
-
Lung Cancer Therapeutics Market Insights by Size, Status And Forecast 2028 – Eudaemonia - Eudaemonia
Posted: September 6th, 2021, 11:31am GMT
-
Ongoing Research Pushes Precision Oncology Mindset in Gastrointestinal Cancers - OncLive
Posted: September 6th, 2021, 11:06am GMT
-
FDA requires monitoring of long-term clinical outcomes for robotic surgery in breast cancer - The Cancer Letter
Posted: September 3rd, 2021, 2:27pm GMT
-
Systemic Therapy for Advanced Neuroendocrine Tumors - OncLive
Posted: September 3rd, 2021, 10:05am GMT
-
Cushing's syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review - DocWire News
Posted: September 3rd, 2021, 4:00am GMT
-
Global Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET) - openPR
Posted: September 2nd, 2021, 11:37am GMT
-
Dr. Layla Ziaee Obituary (2021) St. Louis Post-Dispatch - Legacy.com
Posted: September 2nd, 2021, 5:38am GMT
-
Dexilant Side Effects: What They Are and How to Manage Them - Healthline
Posted: September 2nd, 2021, 5:00am GMT
-
Nutrigenomics Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research - openPR
Posted: September 2nd, 2021, 4:40am GMT
-
Von Hippel-Lindau Disease Therapeutic Market Size Expected to Surge at a CAGR of 8.3% for the Study Period 2018-2030 | DelveInsight - Yahoo Finance
Posted: August 31st, 2021, 3:30pm GMT
-
Survival of Patients With NETs May Depend on Primary Tumor Location - Targeted Oncology
Posted: August 31st, 2021, 12:00pm GMT
Survival of Patients With NETs May Depend on Primary Tumor Location Targeted Oncology -
Recognizing hereditary syndromes in renal cell carcinoma - Urology Times
Posted: August 31st, 2021, 10:20am GMT
Recognizing hereditary syndromes in renal cell carcinoma Urology Times -
NANETS Announces 2021 Basic/Translational Science Investigator Award (BTSI) Recipient - PR.com
Posted: August 31st, 2021, 8:26am GMT
-
North American Neuroendocrine Tumor Society Announces 2021 NANETS Clinical Investigator Scholarship Award Recipient - PR.com
Posted: August 31st, 2021, 8:22am GMT
-
Neuroendocrine Tumor Treatment Market 2021 report explores the future trends, top companies development and forecasts – The Manomet Current - The Manomet Current
Posted: August 31st, 2021, 7:26am GMT
-
Ultrasound and survival for pancreatic ductal adenocarcinoma | CMAR - Dove Medical Press
Posted: August 31st, 2021, 6:20am GMT
Ultrasound and survival for pancreatic ductal adenocarcinoma | CMAR Dove Medical Press -
Harbour BioMed Reports 2021 Interim Results - PRNewswire
Posted: August 31st, 2021, 3:47am GMT
Harbour BioMed Reports 2021 Interim Results PRNewswire -
Embolization Coils Market Growth Steady at 4.8% CAGR to Reach US$ 1,131.24 Million by 2027: COVID-19 Impact an - openPR
Posted: August 30th, 2021, 1:51pm GMT
-
North America Neuroendocrine Tumors Market 2021 Top Key Players And Industry by End-User Segments Forecast Till 2028 – UNLV The Rebel Yell - UNLV The Rebel Yell
Posted: August 30th, 2021, 9:43am GMT
-
Things You Don't Know About Targeted Cancer Therapies Market – UNLV The Rebel Yell - UNLV The Rebel Yell
Posted: August 30th, 2021, 7:05am GMT
-
Novartis presents important overall survival and quality-of-life results across solid tumor portfolio, among other - GlobeNewswire
Posted: August 30th, 2021, 3:15am GMT
-
Dr Boreham’s Crucible: With five trials and $100m, cancer-hunter Clarity’s future is clear - Stockhead
Posted: August 29th, 2021, 5:48pm GMT
-
Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to H | IJGM - Dove Medical Press
Posted: August 28th, 2021, 1:55pm GMT
-
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung - DocWire News
Posted: August 28th, 2021, 4:00am GMT
-
An Overview of Treatment Approaches for Neuroendocrine Tumors - OncLive
Posted: August 27th, 2021, 3:30pm GMT
-
Neuroendocrine Tumors: Factors That Inform Therapy Selection - OncLive
Posted: August 27th, 2021, 3:30pm GMT
-
AHN Cancer Institute Recruits Top Physician-Researchers from UPMC For High Level Roles - WFMZ Allentown
Posted: August 27th, 2021, 2:00pm GMT
-
AHN Cancer Institute Recruits Top Physician-Researchers from UPMC For High Level Roles - WFMZ Allentown
Posted: August 27th, 2021, 2:00pm GMT
-
Significance of HHLA2 Protein in Hepatocellular Carcinoma | JIR - Dove Medical Press
Posted: August 27th, 2021, 1:41pm GMT
Significance of HHLA2 Protein in Hepatocellular Carcinoma | JIR Dove Medical Press -
Tumor DNA Analysis Could Be Useful in Assessing Disease Course - Cushing's Disease News
Posted: August 27th, 2021, 1:14pm GMT
Tumor DNA Analysis Could Be Useful in Assessing Disease Course Cushing's Disease News -
Kidney Protection with the Radical Scavenger alpha(1)-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy - DocWire News
Posted: August 27th, 2021, 1:01pm GMT
-
Immunotherapy Treatments Across the Spectrum of Urothelial Cancer Stages - Bishoy Faltas - UroToday
Posted: August 27th, 2021, 11:50am GMT
-
North America Neuroendocrine Tumors Market Popular Trends & Technological Advancements To Watch Out - PharmiWeb.com
Posted: August 27th, 2021, 11:23am GMT
-
Optical Genome Mapping Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research - openPR
Posted: August 27th, 2021, 6:20am GMT
-
Press Release : Novartis presents important overall survival and quality-of-life results across solid tumor portfolio, among other key data at ESMO - Marketscreener.com
Posted: August 27th, 2021, 5:00am GMT
-
FDA Approves Welireg for Tumors Associated With VHL Disease - Pharmacy Practice News
Posted: August 27th, 2021, 2:03am GMT
FDA Approves Welireg for Tumors Associated With VHL Disease Pharmacy Practice News -
FDA Approves Welireg for Tumors Associated With VHL Disease - Clinical Oncology News
Posted: August 26th, 2021, 7:11pm GMT
FDA Approves Welireg for Tumors Associated With VHL Disease Clinical Oncology News -
FDA Approves Welireg for Tumors Associated With VHL Disease - Clinical Oncology News
Posted: August 26th, 2021, 7:11pm GMT
FDA Approves Welireg for Tumors Associated With VHL Disease Clinical Oncology News -
Research finds neuroendocrine tumor mortality patterns to inform treatment decisions - Mirage News
Posted: August 26th, 2021, 12:28pm GMT
-
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions - The Times Herald
Posted: August 26th, 2021, 12:07pm GMT
-
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions - Montgomery Newspapers
Posted: August 26th, 2021, 12:07pm GMT
-
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions - Clearfield Progress
Posted: August 26th, 2021, 12:07pm GMT
-
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions - PRNewswire
Posted: August 26th, 2021, 12:07pm GMT
-
All Cancers May Fall Into One of Two Classes - Technology Networks
Posted: August 26th, 2021, 11:57am GMT
All Cancers May Fall Into One of Two Classes Technology Networks -
All Cancers May Fall Into One of Two Classes - Technology Networks
Posted: August 26th, 2021, 11:57am GMT
All Cancers May Fall Into One of Two Classes Technology Networks -
Future Directions in Treatment of Small Cell Lung Cancer - OncLive
Posted: August 26th, 2021, 11:20am GMT
-
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions - Newswise
Posted: August 26th, 2021, 10:55am GMT
-
UK HealthCare Launches Pediatric Neuroendocrine Tumor Program - UKNow
Posted: August 26th, 2021, 6:00am GMT
-
Study describes factors associated with cancer-specific death for patients diagnosed with NETs - News-Medical.Net
Posted: August 26th, 2021, 5:00am GMT
-
Global Neuroendocrine Tumors Market Trends by Key Players, End User, Demand, Analysis Growth and Forecast 2028 – UNLV The Rebel Yell - UNLV The Rebel Yell
Posted: August 25th, 2021, 4:17pm GMT
-
Europe Neuroendocrine Tumors Market Potential Growth, Share, Demand and Analysis Of Key Players- Research Forecast To 2028 – UNLV The Rebel Yell - UNLV The Rebel Yell
Posted: August 25th, 2021, 3:09pm GMT
-
Does proton therapy have a role in the treatment of brain tumors? - Healio
Posted: August 25th, 2021, 2:50pm GMT
-
Paraneoplastic syndrome: Connection to small cell lung cancer - Medical News Today
Posted: August 25th, 2021, 2:05pm GMT
Paraneoplastic syndrome: Connection to small cell lung cancer Medical News Today